Literature DB >> 15620709

Gene silencing with STAT6 specific siRNAs blocks eotaxin release in IL-4/TNFalpha stimulated human epithelial cells.

Jörg F Rippmann1, Andreas Schnapp, Andreas Weith, Silke Hobbie.   

Abstract

Small interfering RNAs have evolved as effective tools for the study of gene functions. Here, we demonstrate the use of different siRNAs for the specific knock down of the STAT6 transcription regulator and the complete silencing of the downstream signaling pathway. The knock down of STAT6 resulted in a complete loss of STAT6 specific DNA binding activity and blocked the release of eotaxin-3 in human epithelial cells (BEAS-2B) stimulated with IL-4 and TNFalpha with no signs of unspecific gene silencing. Other signaling pathways like the EGF stimulated release of IL-8 were still active in BEAS-2B cells treated with STAT6 specific siRNAs, demonstrating the specificity of these molecules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15620709     DOI: 10.1016/j.febslet.2004.11.071

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  RNA interference of STAT6 rapidly attenuates ongoing interleukin-13-mediated events in lung epithelial cells.

Authors:  William Walker; Gareth D Healey; Julian M Hopkin
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

2.  Post-transcriptional silencing of CCR3 downregulates IL-4 stimulated release of eotaxin-3 (CCL26) and other CCR3 ligands in alveolar type II cells.

Authors:  Equar Taka; Younes J Errahali; Barack O Abonyo; David M Bauer; Ann S Heiman
Journal:  Cytokine       Date:  2008-11-26       Impact factor: 3.861

3.  Identification of small interfering RNA targeting Signal Transducer and Activator of Transcription 6: Characterisation and selection of candidates for pre-clinical development.

Authors:  Gareth D Healey; Shawn Zinnen; Jennifer A Lockridge; Ivan Richards; Neil Evans; William Walker
Journal:  J RNAi Gene Silencing       Date:  2010-08-25

Review 4.  The future of antisense oligonucleotides in the treatment of respiratory diseases.

Authors:  Marina Ulanova; Alan D Schreiber; A Dean Befus
Journal:  BioDrugs       Date:  2006       Impact factor: 5.807

5.  A review of antisense therapeutic interventions for molecular biological targets in asthma.

Authors:  Florin-Dan Popescu; Florica Popescu
Journal:  Biologics       Date:  2007-09

6.  Diesel exhaust particles activate the matrix-metalloproteinase-1 gene in human bronchial epithelia in a beta-arrestin-dependent manner via activation of RAS.

Authors:  Jinju Li; Andrew J Ghio; Seung-Hyun Cho; Constance E Brinckerhoff; Sidney A Simon; Wolfgang Liedtke
Journal:  Environ Health Perspect       Date:  2008-10-29       Impact factor: 9.031

7.  Design of New Polyaspartamide Copolymers for siRNA Delivery in Antiasthmatic Therapy.

Authors:  Emanuela Fabiola Craparo; Salvatore Emanuele Drago; Nicolò Mauro; Gaetano Giammona; Gennara Cavallaro
Journal:  Pharmaceutics       Date:  2020-01-22       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.